Quick Answer
IRONWOOD PHARMACEUTICALS INC reported Cash And Cash Equivalents At Carrying Value of $215.46 million for the year ending 2025.
- IRONWOOD PHARMACEUTICALS INC showed an increase of +143.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from IRONWOOD PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), IRONWOOD PHARMACEUTICALS INC's Cash And Cash Equivalents At Carrying Value has grown by 76.2%.
- Historical annual values: Fiscal year 2025: $215.46 million | Fiscal year 2024: $88.56 million | Fiscal year 2023: $92.15 million | Fiscal year 2022: $656.20 million | Fiscal year 2021: $620.13 million | Fiscal year 2020: $362.56 million | Fiscal year 2019: $177.02 million | Fiscal year 2018: $173.17 million | Fiscal year 2017: $125.74 million | Fiscal year 2016: $54.00 million | Fiscal year 2015: $261.29 million | Fiscal year 2014: $74.30 million | Fiscal year 2013: $75.49 million | Fiscal year 2012: $136.70 million | Fiscal year 2011: $87.28 million | Fiscal year 2010: $44.32 million | Fiscal year 2009: $122.31 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: